UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Fundamentals cover assigning every dollar a role, regular review, and disciplined adjustments to keep your finances on track.
18,222 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A major investment advisor just boosted its stake in the Invesco BulletShares 2027 Corporate Bond ETF by about $76 mi...
XRP holds firm while BTC and ETH slide, buoyed by steady ETF flows into XRP products and a surge in XRP wallet activi...
Starting with $1,000? This guide shows how to identify the ultimate dividend stock with durable payouts, build a smal...
The stock market CAPE ratio has climbed near 40, a level last seen before major crashes in 1929 and 1999, prompting c...
Snowflake is set to report Q1 FY2027 after the market closes, testing whether AI-driven demand translates into real p...
When a top-tier bank drastically shifts its crypto holdings, it sends a clear signal about market risk and opportunit...
Micron Technology posted a robust quarter fueled by AI infrastructure spending, signaling a multi-year path for this ...
As Micron prepares to report on June 24, investors buzz about a potential stock surge. This guide breaks down catalys...
Alphabet delivered margin expansion and robust cloud growth in the latest quarter, underscoring its cash-flow potenti...
Micron shares fell about 7% in mid-morning trading as Broadcom issued a softer AI chip outlook, triggering a broad se...
POET Technologies has logged a 220% surge over the past year, but traders are contending with signs of a potential co...